Table 2 Plasma hTERT mRNA level in NPC patients and its association with clinicopathological factors
Factor | No. | hTERT mRNA (2-△△Ct) −(X ± SD) | F/t value | P value |
|---|---|---|---|---|
Gender | ||||
 Male | 16 | 10.48 ± 4.39 | −0.346 | 0.731 |
 Female | 17 | 11.00 ± 4.31 | ||
Age | ||||
  < 50 yrs | 17 | 11.04 ± 4.84 | 0.395 | 0.696 |
  ≥ 50 yrs | 16 | 10.44 ± 3.75 | ||
Clinical stage | ||||
 I | 4 | 3.35 ± 1.07 | 32.457 | <0.001 |
 II | 5 | 7.46 ± 0.91 | ||
 III | 17 | 11.17 ± 2.06 | ||
 IV | 7 | 15.18 ± 2.93 | ||
N Stage | ||||
 N0 | 4 | 3.35 ± 1.07 | 18.625 | <0.001 |
 N1 | 5 | 7.40 ± 0.95 | ||
 N2 | 17 | 12.04 ± 3.15 | ||
 N3 | 7 | 14.23 ± 2.44 | ||
T Stage | ||||
 T1 | 11 | 6.93 ± 3.34 | 20.839 | <0.001 |
 T2 | 6 | 9.67 ± 2.66 | ||
 T3 | 13 | 12.65 ± 1.72 | ||
 T4 | 3 | 18.67 ± 1.53 | ||